[go: up one dir, main page]

Follow
Nathan Kipniss
Nathan Kipniss
Scientist
Verified email at alum.mit.edu
Title
Cited by
Cited by
Year
CRISPR-mediated programmable 3D genome positioning and nuclear organization
H Wang, X Xu, CM Nguyen, Y Liu, Y Gao, X Lin, T Daley, NH Kipniss, ...
Cell 175 (5), 1405-1417. e14, 2018
2422018
Genetically engineering self-organization of human pluripotent stem cells into a liver bud-like tissue using Gata6
P Guye, MR Ebrahimkhani, N Kipniss, JJ Velazquez, E Schoenfeld, ...
Nature communications 7 (1), 10243, 2016
2082016
Anti-CRISPR-mediated control of gene editing and synthetic circuits in eukaryotic cells
M Nakamura, P Srinivasan, M Chavez, MA Carter, AA Dominguez, ...
Nature communications 10 (1), 194, 2019
1682019
Engineering cell sensing and responses using a GPCR-coupled CRISPR-Cas system
NH Kipniss, PCDP Dingal, TR Abbott, Y Gao, H Wang, AA Dominguez, ...
Nature communications 8 (1), 2212, 2017
1352017
The CRISPR Revolution: What Editing Human DNA Reveals About the Patent System's DNA
R Feldman
UCLA L. Rev. Discourse 64, 392, 2016
72016
Genetically engineering self-organization of human pluripotent stem cells into a liver bud-like tissue using Gata6. Nat Commun 7: 10243
P Guye, MR Ebrahimkhani, N Kipniss, JJ Velazquez, E Schoenfeld, ...
doi. org/10.1038/ncomm s1024 3, 2016
72016
Anti-CRISPR-mediated control of gene editing and synthetic circuits in eukaryotic cells. Nat Commun 10: 194
M Nakamura, P Srinivasan, M Chavez, MA Carter, AA Dominguez, ...
62019
Genetically engineering self-organization of human pluripotent stem cells into a liver bud-like tissue using Gata6. Nat Commun. 2016; 7: 10243
P Guye, MR Ebrahimkhani, N Kipniss, JJ Velazquez, E Schoenfeld, ...
6
Bivalent chimeric engulfment receptors and uses thereof
DM Corey, N Kipniss
US Patent App. 17/154,959, 2021
42021
In vivo gene editing of human hematopoietic stem and progenitor cells using envelope-engineered virus-like particles
VV Botchkarev Jr, S Harrington, M Stoppato, A Justen, C Kimber, ...
Nature Biotechnology, 1-13, 2025
22025
Engineering Cell Sensing and Responses Using a GPCR-Coupled CRISPR-Cas System
PCDP Dingal, NH Kipniss, L Labanieh, Y Gao, LS Qi
bioRxiv, 152496, 2017
12017
Engineering in vitro human hepatic organoids: 103
MR Ebrahimkhani, P Guye, N Kipniss, J Velazquez, R Weiss, L Griffith
Hepatology 60, 249A-250A, 2014
12014
Engineered cd47 proteins and uses thereof
AJ Johnson, W DOWDLE, NH Kipniss
US Patent App. 18/839,130, 2025
2025
Chimeric tim receptors and uses thereof
DM Corey, N Kipniss
US Patent App. 19/019,111, 2025
2025
Compositions and methods for treating cancer with chimeric tim receptors in combination with inhibitors of poly (adp-ribose) polymerase
DM Corey, N Kipniss, G O'Donoghue
US Patent App. 18/041,200, 2025
2025
Efficient, durable and specific in vivo genetic engineering of human hematopoietic stem progenitor cells
VV Botchkarev Jr, S Harrington, M Stoppato, A Justen, C Kimber, ...
HUMAN GENE THERAPY 36 (3-4), E320-E321, 2025
2025
Anti-cd72 chimeric receptors and uses thereof
DM Corey, N Kipniss, Y KOIDE, B Cieniewicz, Y Qu, S Thomas
US Patent App. 18/418,120, 2024
2024
Chimeric tim receptors and uses thereof
DM Corey, N Kipniss
US Patent App. 18/041,195, 2024
2024
Efficient and specific in vivo genetic engineering of human hematopoietic stem progenitor cells without selective conditioning
S Harrington, VV Botchkarev Jr, A Justen, C Kimber, A Kapuria, Y Xu, ...
HUMAN GENE THERAPY 35 (3-4), A21-A21, 2024
2024
Efficient and Specific In Vivo Genetic Engineering of Human Hematopoietic Stem Progenitor Cells without Selective Conditioning
VV Botchkarev Jr, S Harrington, A Justen, C Kimber, A Kapuria, Y Xu, ...
Blood 142, 2252, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20